structure of human testis ACE in complex with a novel C-domain specific inhibitor, to 3.0 Å, which reveals detailed information on the interactions of this inhibitor with the active site.
Non-steroidal antiinflammatory drugs block the cyclooxygenase activity of prostaglandin-H synthase, also known as cyclooxygenase (COX), the enzyme that mediates biosynthesis of eicosanoids from arachidonic acid. Two enzyme isoforms have been identified: COX-1 which is constitutively expressed, and COX-2, which is inducible. Resveratrol (3,5,4 -trihydroxy-trans-stilbene) is a phytoalexin found predominantly in grapes and it has both antiinflammatory and cancer chemopreventive activity. One of the mechanisms of action of resveratrol is believed to be mediated through potent inhibition of COX-1 and COX-2 activity. We have determined the x-ray structure of COX-1 co-crystallized with resveratrol to 2.9 Å resolution using synchrotron radiation (BioCARS beamline 14-BM-C) to determine the binding mode of resveratrol in the active site. Using the crystal structures of COX-1/resveratrol and COX-2/flurbiprofen complexes, we performed computational docking studies of resveratrol and its two (3-and 4'-) sulfate metabolites using Dock 4.0.1. Our results indicate that the computed free energy values of binding for each of the docked resveratrol analogs are commensurate with their experimentally determined inhibition constants (K i ). However, the computational modeling results were unable to predict the selectivity in binding of resveratrol and its metabolites to the two enzymatic isoforms most probably due to the slight differences in binding affinities of these molecules for COX-1 or COX-2. This research is funded by grants from the National Cancer Institute (NIH: R03 CA92744-02 and 5 P01 CA48112-10 EMBL Grenoble Outstation, BP 156, 38042, Grenoble, Cedex 9, France. 4 Computational, Analytical & Structural Sciences, Glaxosmithkline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, Thrombin is a member of the serine proteinase family. The structure consists of two chains. Thrombin plays an important role in the coagulation of blood; contact with fibrinogen results in the formation of fibrin that polymerize into a blood clot.
X-ray data have been measured at ESRF ID 14.4, SRS MPW10 and at APS SBC. The four X-ray diffraction data sets achieved thus far are between 1.26 and 1.4 Å based on <F/ (F)> >2 and completeness > 50%, two bound with hirugen only, and two with an inhibitor as well. We wish to identify hydrogen atoms at the active site and other key water hydrogens that are involved in the cleavage of fibrinogen.
In addition we wish to use neutron crystallography because the scattering factor for neutrons of deuterium equals that of C, N and O. We have so far grown a large (0.7x0.7x~0.3mm) thrombin crystal. Bacteria produce a lot of bioactive and structurally unimaginable compounds. Among them, FR901451 from Flexibaccter sp. No.758 is known to have large tri-macrocyclic structure and to inhibit porcine pancreatic elastase, which in turn resembles the attractive drug target leukocyte elastase [1] . The crystal structure of FR901451 as bound to pancreatic elastase was solved at 2.5 Å resolution. The inhibitor occupies the most prominent subsites S1' to S3 of the elastase and prevents a hydrolytic attack by covering the active center with its rigid ring structure. The observed binding structure may help to design potent elastase inhibitors.
synchrotron radiation, clearly show that the catalytic site is fully occupied by a single ordered molecule (see Figure) . This permitted unambiguously the identification of nature and stereochemistry of the bound inhibitor. Furthermore, the clear electron density map, without residuals, suggests that the inhibition constant of this compound should be at least one order of magnitude lower than the constants of the other compounds. The full occupancy of the site indicates that its value is less than 1µM. This biocrystallographic study has allowed a first assessment of inhibition properties without the purification of the mixture and the classic activity assays that are normally conducted on each compound. The co-crystallization strategy could be applied in conjunction with combinatorial chemistry synthesis to discover, by self selection, new potent inhibitors. Disintegrins are a family of small proteins that bind to integrins specifically. Their binding site is characterized by the presence of Arg-Gly-Asp motif which indicates an RGD-dependant mode of interaction with integrins. The disintegrins interfere with the functions of integrins as antagonists. Disintegrin was isolated from the venom of Echis carinatus and crystallized in the tetragonal space group P4 3 2 1 2 with a=b=90.7Å and c=55.5Å. It exits as a heterodimer unlike the low resolution structure which existed as a homodimer with its two subunits related by a two fold crystallographic symmetry. It is interlinked by two disulfide bonds at the N-terminal region and contains 64 amino acid residues in each chain. Each monomer contains three pairs of six antiparallel -strands and is stabilized by four disulphide bridges. It has been refined to an R-factor of 0.212 and R free of 0.251 for all the data. The two chains of the dimer are anchored at N-terminal but diverge away at their C-termini exposing the Arg-Gly-Asp motif onto opposite directions, thus enhancing their binding efficiency. This is one of its unique features. The structural studies of disintegrins can provide a useful framework for the design of potent antagonists of integrins. Sciences, 354 Fenglin Lu, Shanghai 200032, China. E-mail: yanght@xtal.tsinghua.edu.cn Coronaviruses (CoVs) are important etiologic agents of upper respiratory and digestive tract diseases in humans and animals; especially, the severe acute respiratory syndrome (SARS). The viruses are characterized with a highly complex cascade of proteolytic processing the replicative polyproteins to control viral gene expression and replication, which was predominantly mediated by the viral main proteinase (M pro , also called 3CL pro ), therefore, an attractive target for drug development [1] . A series of novel compounds with Michael receptor was designed according to the crystal structures of 3 coronaviruses M pro s. The solved structures of SARS-CoV and porcine transmissible gastroenteritis virus (TGEV) M pro s individually complexed with these compounds revealed that inhibitors possessing , -unsaturated ester combined with peptidyl-binding elements specific for CoV M pro s undergo a nucleophilic addition of the protease's catalytic Cys, resulting in covalent-bond formation and irreversible inactivation of the viral proteases. One compound in this series has exhibited potent and extensive inhibition effect on 6 CoV M pro s covering all 4 groups within genus Coronavirus. Meanwhile, the novel small molecules showed low micromolar concentration of EC 50 for inhibition of viral replication and very low cell toxicity. We suppose further modification of these compounds assisted with structural information might lead to discover drug candidates against all CoV-associated diseases, including SARS.
